How Cinapsis Helps NHS Teams Work as One
December 22, 2025
.svg)
April 23, 2026
National elective waiting list figures continue to dominate health policy discussion across England. Each monthly update brings renewed focus on whether the NHS is making progress in reducing the backlog.
Yet the headline numbers only tell part of the story.
In some parts of England, specialised NHS teams deployed through the Further Faster 20 (FF20) programme have helped waiting lists fall three times faster than the national average over a 12-month period. That level of improvement isn’t simply a result of adding more clinical capacity. It reflects a deeper shift in how systems are approaching demand, referral management, and pathway redesign.
Understanding what sits behind those results offers useful insight into how waiting list recovery might be sustained over the long term.
When waiting lists rise, the instinctive response is often to increase throughput:
These measures can help address immediate pressure, but they largely focus on one side of the equation: throughput.
What they don’t change is the rate at which patients enter the system in the first place.
The FF20 evaluation highlights this distinction. Trusts participating in the programme saw waiting lists fall by around 4.2% over a year, compared with 1.4% nationally, even though national demand pressures and activity levels remained broadly similar. Among working-age adults, the divergence was even more pronounced.
This suggests that operational improvement, including smarter triage, outpatient transformation, and redesigned referral pathways, can materially change how patient queues behave over time.
Reducing waiting lists sustainably isn’t just about increasing the number of appointments available. Increasingly, NHS systems are recognising that the more powerful lever lies earlier in the pathway: managing demand before it becomes waiting list pressure.
In systems where waiting lists are falling faster, several common approaches are emerging:
Together, these changes act as a form of demand management in healthcare, reducing the number of patients added to specialist waiting lists while improving the appropriateness of those who are referred
A growing share of NHS pathway redesign efforts are now focused on the “front door” to secondary care.
This includes establishing clearer and more consistent referral thresholds, building structured specialist advice workflows, and creating systems where clinicians can access expertise without automatically escalating a patient into a full referral.
Models such as Advice and Guidance (A&G) are increasingly playing a role here. When implemented well, they do more than facilitate communication between clinicians; they become part of the clinical decision pathway itself.
However, for these approaches to be effective at scale, systems also need visibility. Without consistent metrics showing where referrals originate, how often cases are resolved upstream, and where diversion occurs, it is difficult to fully understand how demand flows through the system.
Waiting list figures alone only show the outcome, not the underlying behaviour that drives them.
Even as treatment activity has increased in recent years, referral growth often continues to outpace available capacity.
National statistics show that while some waiting list measures have recently begun to fall, the total number of patients waiting for elective care remains significantly above constitutional targets.
That is why reducing inappropriate referrals plays such a critical role in waiting list recovery. Slowing the rate at which new patients join the waiting list strengthens the impact of increased treatment activity and allows backlog reduction to compound over time.
Put simply: the fewer patients added unnecessarily, the easier it becomes to reduce the overall queue.
There is also an important workforce dimension to pathway redesign.
Increasing clinic numbers without addressing underlying demand patterns can place additional pressure on already stretched specialist teams. Large volumes of low-complexity cases often consume time that could be better spent managing complex patients who genuinely require specialist expertise.
More effective demand filtering helps rebalance this dynamic. By ensuring that referrals are more appropriate and better prepared, clinicians can focus their time where it has the greatest clinical impact.
The result is not just improved operational performance, but a more sustainable model of care delivery.
Reducing waiting lists in the short term will always require increased activity. But the systems delivering the most consistent improvements are increasingly focusing on something broader: long-term pathway transformation.
This means developing:
Throughput helps clear waiting lists. But intelligent pathway design helps keep them down.
Waiting list reductions will continue to attract headlines. Yet the deeper transformation happens earlier in the patient journey, in how referrals are made, how clinical advice is accessed, and how demand is managed across the system.
Ultimately, sustainable waiting list improvement depends on controlling both sides of the queue: how many patients are treated, and how many are added in the first place.
That is the real promise of pathway redesign in the NHS.
.svg)
